These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 8866788)

  • 1. Increased cAMP and cAMP-dependent protein kinase activity mediate anti-CD2 induced suppression of anti-CD3-driven interleukin-2 production and CD25 expression.
    Lin J; Gettys TW; Qin L; Chavin KD; Yang Q; Ding Y; Punch JD; Bromberg JS
    Pathobiology; 1995; 63(4):175-87. PubMed ID: 8866788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD3 and CD2 ligation alters CD49d epitope expression.
    Lin J; Qin L; Chavin KD; Ding Y; Punch JD; Yang Q; Burkly LC; Bromberg JS
    Pathobiology; 1995; 63(3):119-32. PubMed ID: 8821628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenosine inhibits activation-induced T cell expression of CD2 and CD28 co-stimulatory molecules: role of interleukin-2 and cyclic AMP signaling pathways.
    Butler JJ; Mader JS; Watson CL; Zhang H; Blay J; Hoskin DW
    J Cell Biochem; 2003 Aug; 89(5):975-91. PubMed ID: 12874832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A humanised therapeutic CD4 mAb inhibits TCR-induced IL-2, IL-4, and IL-10 secretion and expression of CD25, CD40L, and CD69.
    Woods M; Guy R; Waldmann H; Glennie M; Alexander DR
    Cell Immunol; 1998 May; 185(2):101-13. PubMed ID: 9636688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-CD2 and anti-CD3 monoclonal antibodies synergize to prolong allograft survival with decreased side effects.
    Chavin KD; Qin L; Lin J; Kaplan AJ; Bromberg JS
    Transplantation; 1993 Apr; 55(4):901-8. PubMed ID: 8097344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Up-regulation of IL-4 production by the activated cAMP/cAMP-dependent protein kinase (protein kinase A) pathway in CD3/CD28-stimulated naive T cells.
    Tokoyoda K; Tsujikawa K; Matsushita H; Ono Y; Hayashi T; Harada Y; Abe R; Kubo M; Yamamoto H
    Int Immunol; 2004 May; 16(5):643-53. PubMed ID: 15096485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Costimulatory signals modulate the antiproliferative effects of agents that elevate cAMP in T cells.
    Bartik MM; Bauman GP; Brooks WH; Roszman TL
    Cell Immunol; 1994 Oct; 158(1):116-30. PubMed ID: 8087859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effects of anti-CD2 monoclonal antibodies on interleukin 2 production and interleukin 2 receptor expression in anti-CD3-induced T cell activation.
    Stohl W; Linker-Israeli M
    Cell Immunol; 1989 May; 120(2):351-65. PubMed ID: 2566387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-stimulation of human peripheral blood mononuclear cells with IL-2 and anti-CD3 monoclonal antibodies induces phosphorylation of CREB.
    Guyot DJ; Newbound GC; Lairmore MD
    Immunol Lett; 1998 Mar; 61(1):45-52. PubMed ID: 9562374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD2 and CD3 receptor-mediated tolerance: constraints on T cell activation.
    Punch JD; Lin J; Bluestone J; Bromberg JS
    Transplantation; 1999 Mar; 67(5):741-8. PubMed ID: 10096532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of interleukin-2 and interferon-gamma and maintenance of interleukin-4 and interleukin-10 production after administration of an anti-CD3 monoclonal antibody in mice.
    Wissing KM; Desalle F; Abramowicz D; Willems F; Leo O; Goldman M; Alegre ML
    Transplantation; 1999 Sep; 68(5):677-84. PubMed ID: 10507488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of anti-CD3 monoclonal antibody-induced T-cell proliferation and interleukin-2 secretion by physiologic combinations of dexamethasone and prostaglandin E2.
    Elliott L; Brooks W; Roszman T
    Cell Mol Neurobiol; 1993 Dec; 13(6):579-92. PubMed ID: 7910781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of anti-CD3 antibody-induced mouse T cell activation by pentoxifylline in combination with rapamycin or A77 1726 (leflunomide).
    Richard M; Hoskin DW
    Int J Immunopharmacol; 1998; 20(4-5):241-52. PubMed ID: 9730259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation.
    de Waal Malefyt R; Yssel H; de Vries JE
    J Immunol; 1993 Jun; 150(11):4754-65. PubMed ID: 7684412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-CD2 monoclonal antibody-induced receptor changes: down modulation of cell surface CD2.
    Lin J; Yon RW; Chavin KD; Qin L; Woodward J; Ding Y; Yagita H; Bromberg JS
    Transplantation; 1995 Apr; 59(8):1162-71. PubMed ID: 7537394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition by anti-CD2 monoclonal antibodies of anti-CD3-induced T cell-dependent B cell activation.
    Stohl W; Crow MK
    Cell Immunol; 1990 Oct; 130(2):257-70. PubMed ID: 1976440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-CD2 monoclonal antibody-induced receptor changes. II. Interaction of CD2 and CD3.
    Lin J; Chavin KD; Qin L; Ding Y; Bromberg JS
    Cell Immunol; 1996 Feb; 167(2):249-58. PubMed ID: 8603434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholera toxin inhibits the increase in cytoplasmic free calcium induced via the CD2 pathway of human T-lymphocyte activation.
    Nunes J; Bagnasco M; Lopez M; Olive D; Mawas C
    J Cell Biochem; 1989 Apr; 39(4):391-400. PubMed ID: 2542344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenosine 3',5'-cyclic monophosphate (cAMP)-dependent inhibition of IL-5 from human T lymphocytes is not mediated by the cAMP-dependent protein kinase A.
    Staples KJ; Bergmann M; Tomita K; Houslay MD; McPhee I; Barnes PJ; Giembycz MA; Newton R
    J Immunol; 2001 Aug; 167(4):2074-80. PubMed ID: 11489990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel model for antigen-dependent activation of normal human T cells. Transmembrane signaling by crosslinkage of the CD3/T cell receptor-alpha/beta complex with the cluster determinant 2 antigen.
    Suthanthiran M
    J Exp Med; 1990 Jun; 171(6):1965-79. PubMed ID: 1972176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.